<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>FDA on Alan Dove, Ph.D.</title>
    <link>https://alandove.com/tags/fda/</link>
    <description>Recent content in FDA on Alan Dove, Ph.D.</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>Alan Dove</copyright>
    <lastBuildDate>Thu, 15 Jan 2009 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://alandove.com/tags/fda/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>From Jamaica Ginger to Vicks VapoRub</title>
      <link>https://alandove.com/posts/2009/2009-01-15-from-jamaica-ginger-to-vicks-vaporub/</link>
      <pubDate>Thu, 15 Jan 2009 00:00:00 +0000</pubDate>
      <guid>https://alandove.com/posts/2009/2009-01-15-from-jamaica-ginger-to-vicks-vaporub/</guid>
      <description>A new paper in the journal CHEST presents the case of a toddler who went into respiratory distress after receiving a smear of Vicks VapoRub under her nose. To figure out what happened, the researchers replicated the treatment in ferrets, whose respiratory systems are a good model for humans. The results were not exactly consistent with the Vicks &amp;ldquo;Breathe free&amp;rdquo; slogan:&#xA;[VapoRub] stimulates mucin secretion and [mucociliary transport] in the &amp;hellip; inflamed ferret airway.</description>
    </item>
  </channel>
</rss>
